Folate receptor alpha (FRα), which is a glycosylated phosphatidylinositol-anchored glycoprotein, is highly expressed in a variety of cancers, including head and neck cancer24, breast cancer25, and ovarian cancer26, as well as NSCLC27–30. Here, FOLR1 is linked to cancer.